Surge in COVID-19 testing demand spurs labs to ration other tests

Read the full short article here..

Dr. Godbey and other experts expect scarcities to intensify with an increase in influenza screening and COVID-19 cases spiking throughout the country..

Due to lacks, Planned Parenthood South Atlantic is no longer offering gonorrhea and chlamydia testing to every client, its CMO Katherine Farris, MD, informed the Journal..

A rise in demand for COVID-19 screening has actually drained products needed for other types of screening, such as for strep throat, fungal infections and sexually transmitted illness, and some labs have actually needed to ration testing, The Wall Street Journal reported..

A lack of swabs, chemicals and other equipment needed to conduct and process tests has forced some laboratories to limit how numerous samples they can process and what diseases they can test for. About 30 percent of labs surveyed the week of Oct. 26 by the American Society for Microbiology and the Association of Supply Chain Management reported scarcities of supplies needed to detect strep throat, bronchitis and urinary system infections, the Journal reported. © Copyright ASC COMMUNICATIONS 2020.

A lack of swabs, chemicals and other devices needed to conduct and process tests has actually forced some laboratories to restrict how lots of samples they can process and what illness they can test for. About 30 percent of labs surveyed the week of Oct. 26 by the American Society for Microbiology and the Association of Supply Chain Management reported scarcities of supplies needed to identify strep throat, bronchitis and urinary tract infections, the Journal reported. Half of the 127 labs stated they were brief on supplies to test for infections varying from shallow skin problem to serious lung and blood diseases..

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

Maia Anderson –
Monday, November 9th, 2020
Print|Email.

More posts on supply chain: CDC seeks to create centralized reporting system for COVID-19 test resultsAbbott takes legal action against former exec, declares he shared trade secretsFDA warns of potential for incorrect positives in coronavirus antigen tests.

” We make the best of what we can, but the bottom line is, we still cant get enough reagents. We still cant get sufficient consumables,” Patrick Godbey, MD, president of the College of American Pathologists, informed the Journal..

The University of North Carolina Medical Center has faced lacks of supplies to check MRSA, an antibiotic-resistant germs that triggers staph infections, Melissa Miller, PhD, director of microbiology laboratories at the Chapel Hill-based medical center informed the Journal..

The most severe shortages have actually been for supplies required to find chlamydia and gonorrhea, diseases which can damage reproductive health. About 43 percent of the labs surveyed reported lacks for those tests and tests for other sexually transmitted illness, the Journal reported..